The U.S. Patent Office upholds a trio of KCI patents in the worldwide battle over negative-pressure wound therapy patents between the Texas wound care firm and the British conglomerate.
The worldwide wound care war went another round after Kinetic Concepts Inc. won a patent decision over rival Smith & Nephew.
After re-examining a trio of KCI negative-pressure wound therapy patents, the U.S. Patent and Trademark Office confirmed their validity.
That makes the score just about even, as the San Antonio, Texas-based wound care firm has notched victories here and in Australia, while the British conglomerate won decisions in Germany and the United Kingdom over equivalent intellectual property.
Smith & Nephew, which houses its endoscopy division in Andover, Mass., said it plans to appeal the latest U.S. Patent Office decision.
As for KCI, the firm seems confident it will prevail in all the various arenas, naming Michael Genau to its newly created global president of wound therapy position, where he'll lead the company's expansion plans for the division.
Warren Watson, a 30-year Medtronic Inc. employee with family connections to founder Earl Bakken, is...
Quidel Corp. wins Food & Drug Administration 510(k) clearance for its chorionic gonadotropin-...
Ann Arbor, Mich.-based HistoSonics Inc. snags former Food & Drug Administration commissioner Dr....
The Food & Drug Administration releases a list of the medical devices it granted 510(k) clearance...
A federal grand jury indicts former Spectranetics CEO John Schulte, two other executives and a...